Nichiban Co., Ltd.
Stock Price Chart
2026/07/31 UpdatedPrice Trend
2026/07/31 UpdatedPrice & Trading Details
2026/07/31 UpdatedPRICE
TRADING
Analyst Recommendations 1 analysts
Updated 2026/07/01Shareholder Composition
Updated 2026/07/01Major Holders
Updated 2026/07/01| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Vanguard International Stock Index-Total Intl Stock Indx
|
141.3K | 0.00% | |
|
Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund
|
82.0K | -18.00% | |
|
DFA Japanese Small Company Series
|
62.4K | -8.37% | |
|
DFA International Core Equity Portfolio
|
47.1K | +13.77% | |
|
Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index
|
34.3K | 0.00% | |
|
Vanguard Intl Equity Index - Total World Stock Index Fd
|
14.5K | 0.00% |
Dividend History 1Years Growth
Updated 2026/07/26| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥40 | +14.3% |
| 2025 | ¥35 | 0.0% |
| 2024 | ¥35 | 0.0% |
| 2023 | ¥35 | +16.7% |
| 2022 | ¥30 | - |
Financial Performance
2026/07/26 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥45,560M | ¥46,859M | ¥49,457M | ¥50,470M |
| Gross Profit | ¥12,974M | ¥13,871M | ¥14,902M | ¥15,025M |
| Operating Income | ¥1,609M | ¥2,073M | ¥2,587M | ¥2,271M |
| Pretax Income | ¥3,468M | ¥2,310M | ¥2,667M | ¥2,169M |
| Net Income | ¥2,371M | ¥1,827M | ¥1,959M | ¥1,652M |
| EPS | ¥114.65 | ¥88.97 | ¥96.23 | ¥81.17 |
| Operating Margin | 3.53% | 4.42% | 5.23% | 4.50% |
| Balance Sheet | ||||
| Total Assets | ¥69,123M | ¥68,039M | ¥67,603M | ¥67,307M |
| Total Equity | ¥40,602M | ¥41,702M | ¥43,186M | ¥44,324M |
| Total Liabilities | ¥28,521M | ¥26,337M | ¥24,417M | ¥22,983M |
| Cash | ¥15,108M | ¥13,405M | ¥14,663M | ¥13,730M |
| Interest-bearing Debt | ¥2,171M | ¥2,134M | ¥2,135M | ¥2,171M |
| Equity Ratio | 58.74% | 61.29% | 63.88% | 65.85% |
| D/E Ratio | 0.05 | 0.05 | 0.05 | 0.05 |
| Cash Flow | ||||
| Operating CF | ¥2,917M | ¥3,187M | ¥3,690M | ¥2,540M |
| Investing CF | -¥1,153M | -¥3,692M | -¥1,695M | -¥2,238M |
| Financing CF | -¥867M | -¥1,225M | -¥763M | -¥1,114M |
| Free CF | ¥22M | -¥577M | ¥2,307M | ¥328M |
| Efficiency | ||||
| ROE | 5.84% | 4.38% | 4.54% | 3.73% |
| ROA | 3.43% | 2.69% | 2.90% | 2.45% |
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥2,780
Rating Score: - (Based on 1 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Nichiban Co., Ltd. develops, manufactures, and sells medical products and tapes in Taiwan, Asia, Europe, and internationally. The company offers medical products, including surgical tapes, wound care dressing tapes, post-operative care tapes, cornea protection tapes, and hemostatic and first-aid bandages; and sports tapes, underwraps, scissors, and bags. It also provides navel compression pack, which is used for umbilical hernia compression treatment in infants. In addition, the company offers industrial tapes for use in packaging, carton boxes, agriculture, vehicles, construction, home appliances and electronic materials, and machinery applications, as well as adhesive tapes; cloth tapes; bag sealing machines; washi masking tapes; and sealing machines. Further, the company provides stationery and office products comprising cellulose adhesive tapes, dispensers, double sided tapes, adhesive transfer tapes, book binding tapes, and others. Nichiban Co., Ltd. was founded in 1918 and is headquartered in Tokyo, Japan.
